Skip to content

Research paper

Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial.

The Journal of clinical endocrinology and metabolism
Q1
Sep 2013
Citations: 132
Influential: 4
Interventional (Human) Studies
90

Study answer

What this study found

Vitamin D3 was more effective than vitamin D2 at raising total 25(OH)D. In the vitamin D3 group, total 25(OH)D increased from 43.7 ± 23.3 to 89.2 ± 22.1 nmol/L and 25(OH)D3 increased from 41.5 ± 22.8 to 88.0 ± 22.1 nmol/L after 8 weeks. In the vitamin D2 group, total 25(OH)D increased from 37.6 ± 13.3 to 67.8 ± 20.1 nmol/L, but 25(OH)D3 fell from 36.4 ± 13.3 to 16.6 ± 6.3 nmol/L while 25(OH)D2 rose to 51.2 ± 18.5 nmol/L. Between-group differences were significant (ANOVA P = .001), no adverse effects were reported, and serum calcium remained within the normal range. These findings support…

Study & population
Randomized, placebo-controlled, parallel-group trial in healthy adult volunteers in Halle (Saale), Germany, conducted during winter (January to March 2012) when UVB exposure was minimal.
Intervention
Participants received one oral tablet daily for 8 weeks containing either vitamin D2 (ergocalciferol) 50 µg/d or vitamin D3 (cholecalciferol) 50 µg/d (2000 IU/d), versus placebo in the parent trial.
Key limitation
The trial was short (8 weeks), single-center, and conducted in healthy adults during one winter season, which limits generalizability.
View sourceOpen PDF

Original abstract

BACKGROUND The bioequivalence of the different forms of vitamin D, ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), has been questioned. Earlier studies have suggested that vitamin D2 is less biologically active than vitamin D3. OBJECTIV…